Accelerate Diagnostics Inc (FRA:1A80)
€ 1.74 -0.01 (-0.57%) Market Cap: 40.14 Mil Enterprise Value: 70.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q2 2019 Accelerate Diagnostics Inc Earnings Call Transcript

Aug 08, 2019 / 08:30PM GMT
Release Date Price: €151.1 (+1.98%)
Operator

Good day, everyone, and welcome to the Accelerate Diagnostics Q2 2019 Earnings Conference Call. (Operator Instructions) And also note, today's event is being recorded.

At this time, I'd like to turn the conference call over to Ms. Laura Pierson. Ma'am, you may begin.

Laura Pierson
Accelerate Diagnostics, Inc. - IR Officer

Before we begin, it is important to share that information presented during this call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Forward-looking statements include projections, statements about our future and those that are not historical facts. All forward-looking statements that are made during this conference call are subject to risks, uncertainties and other factors that could cause our actual results to differ materially. These are discussed in greater detail in our annual report on Form 10-K for the year ended December 31, 2018, and other reports we file with the SEC.

It is my pleasure to now

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot